Smith & Nephew SNATS (NYSE:SNN) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Smith & Nephew SNATS (NYSE:SNN) from a buy rating to a strong-buy rating in a research report report published on Saturday morning.

Separately, Canaccord Genuity Group lifted their price target on Smith & Nephew SNATS from $28.00 to $36.00 and gave the company a “hold” rating in a research note on Monday, August 18th. Six investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Smith & Nephew SNATS currently has a consensus rating of “Hold” and an average price target of $36.00.

Smith & Nephew SNATS Stock Up 0.7%

Shares of SNN opened at $37.47 on Friday. Smith & Nephew SNATS has a 52 week low of $23.69 and a 52 week high of $37.65. The company has a quick ratio of 1.40, a current ratio of 3.00 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $16.41 billion, a price-to-earnings ratio of 17.35, a PEG ratio of 1.03 and a beta of 0.68. The stock’s 50-day moving average price is $32.81 and its 200-day moving average price is $29.67.

Smith & Nephew SNATS Cuts Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 3rd will be paid a $0.285 dividend. This represents a dividend yield of 210.0%. The ex-dividend date is Friday, October 3rd. Smith & Nephew SNATS’s payout ratio is currently 41.20%.

Institutional Investors Weigh In On Smith & Nephew SNATS

Several institutional investors have recently bought and sold shares of SNN. Hara Capital LLC boosted its holdings in Smith & Nephew SNATS by 391.4% in the 4th quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider’s stock worth $60,000 after buying an additional 1,957 shares during the last quarter. Barclays PLC acquired a new stake in Smith & Nephew SNATS in the 4th quarter worth about $431,000. First Trust Advisors LP acquired a new stake in Smith & Nephew SNATS in the 4th quarter worth about $248,000. Stifel Financial Corp boosted its holdings in Smith & Nephew SNATS by 19.5% in the 4th quarter. Stifel Financial Corp now owns 48,292 shares of the medical equipment provider’s stock worth $1,187,000 after buying an additional 7,893 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in Smith & Nephew SNATS by 169.9% in the 4th quarter. Northern Trust Corp now owns 508,392 shares of the medical equipment provider’s stock worth $12,496,000 after buying an additional 320,054 shares during the last quarter. 25.64% of the stock is currently owned by institutional investors and hedge funds.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.